Form 4: William Fisher Sells 243K GAP Shares at $23.82 Avg
Rhea-AI Filing Summary
William Sydney Fisher reported a sale of 243,064 shares of The Gap, Inc. (GAP) executed on 09/04/2025 at a weighted average price of $23.8154 per share. The filing lists his beneficial ownership following the reported transactions as 3,453,453 shares held indirectly by a trust, 150,061 shares held indirectly by spouse, and 22,015,000 shares held indirectly by limited partnerships. The form was signed by an attorney-in-fact on 09/05/2025. The filer certified that the reported sale was executed in multiple trades at prices ranging from $23.50 to $23.985 and offered to provide full trade details on request.
Positive
- None.
Negative
- Insider disposition: William Sydney Fisher reported a sale of 243,064 GAP shares on 09/04/2025 at a weighted average price of $23.8154.
- Range disclosed: The filing states the trades occurred at prices between $23.50 and $23.985, indicating multiple transactions rather than a single block trade.
Insights
TL;DR: Insider sale of 243,064 GAP shares at ~$23.82 is disclosed; overall indirect holdings remain substantial.
The Form 4 discloses an open-market disposition of 243,064 shares executed across multiple trades at prices between $23.50 and $23.985, producing a weighted average of $23.8154. Post-transaction beneficial holdings are shown as large indirect positions across a trust, spouse and limited partnerships, totaling tens of millions of shares when combined. This disclosure is routine for a Section 16 reporting person and provides transparency about an insider liquidity event but does not by itself quantify timing intent or broader portfolio changes.
TL;DR: Filing meets Section 16 reporting requirements; sale documented and signature provided by attorney-in-fact.
The submission includes the required signature by an attorney-in-fact and an explicit explanation of the weighted average price calculation, which supports compliance and traceability. Large indirect holdings remain disclosed, indicating continued significant beneficial ownership despite the reported sale. There is no additional corporate action, insider role change, or regulatory exception noted in the filing.